The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
challenges in human health. Within the Computational Biology Research Centre, HT hosts a core experimental unit (DGEV) that provides support for the creation of novel molecular datasets from clinically
-
to high dimensional, omics datasets. Our group is extremely collaborative both through formal participation in consortia and through informal collaborations with research investigators, physician scientists
-
stands as a unique hub for groundbreaking cancer glycomics research, where world-renowned experts in both basic science and clinical research collaborate, utilizing state-of-the-art equipment and advanced
-
in Copenhagen. Principal investigators include clinicians, basic scientists, data scientists, and epidemiologists. In addition to national partnerships, PREDICT has strong collaborations with leading
-
research on health register/clinical data as well as molecular and ‘omics data generated from biospecimens and in-vitro exposure paradigms. The main aim of the proposed research program is to disentangle
-
an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description LMU Munich is one of Europe’s leading research institutions. Scientists from all over the world
-
to the mission of the CPHG is training the next generation of genome scientists by providing state-of-the-art research, translational, and teaching experiences. The University of Virginia Comprehensive Cancer
-
such as Institutional Review Board (IRB), and HIPAA. Knowledge of regulatory and data privacy issues. Familiarity with one or more data types such as Electronic Health Records (EHR), radiology, omics
-
and Wallenberg National Program for Data-Driven Life Science (DDLS) aims to recruit and train the next-generation of data-driven life scientists and to create globally leading computational and data
-
characterizations of rare thoracic cancers(1—4). Our results unveiled specialized genomic, transcriptomic, and epigenomic profiles that shape the clinical behavior of the tumors. Nevertheless, the biological